ARWR
#961
Arrowhead Pharmaceuticals, Inc. - Common Stock
62.7 5 USD
+0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
+3.31%
Variación mensual
-24.13%
Variación en los últimos 6 meses
-3.61%
Cambio anual
+60.49%
Cierres anteriores
60.7 4
Open
60.7 2
Mínimo
60.4 8
Máximo
62.9 9
Financials
- Market Capitalization 8.86 B
- Employee 711
- Founded 2004
- CEO Christopher Richard Anzalone
- Website www.arrowheadpharma.com
- Headquarter Delaware, United States
- FIGI BBG000BRVKH0
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-3 449
Relación precio/flujo de caja
5.56
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 931 |  KYMR Kymera Therapeutics, Inc. - Common Stock | 112.40 USD | +2.84% | +3.71% | -3.10% | +90.19% | 9.35 B USD | ||
| 933 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 143.73 USD | +2.73% | +2.04% | -4.13% | +91.31% | 9.30 B USD | ||
| 966 |  AXSM Axsome Therapeutics, Inc. - Common Stock | 168.35 USD | -1.02% | -6.08% | -24.14% | +29.30% | 8.82 B USD | ||
| 970 |  CYTK Cytokinetics, Incorporated - Common Stock | 62.91 USD | +1.45% | -4.14% | -14.42% | +8.28% | 8.75 B USD |